The company also has an InThrill system that removes emboli and thrombi from the peripheral vasculature ... partnership with the Institute for Follicular Lymphoma Innovation (IFLI), a non-profit ...

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma ... with this advanced blood cancer," said Marie ...

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

blood or other organs. CD19-targeted CAR T cells have transformed the management of patients with relapsed and/or refractory large B cell lymphoma, and these therapies are increasingly being ...

In IVLBCL, lymphoma cells develop within blood vessels, which can affect organ function. IVLBCL is very rare. It’s been estimated to occur in fewer than 0.5 out of one million individuals each year.

Liver-projecting vagal sensory neurons play a key role in regulating energy balance, hepatic steatosis, and anxiety-like behavior in mice under obesogenic conditions. Modulating the liver-brain ...

As you age, your risk for higher blood sugar increases—which raises the risk of type 2 diabetes for adults in their 50s, 60s, and 70s. Using a chart of blood sugar levels by age can help you track ...